109 related articles for article (PubMed ID: 31670806)
21. Akt up-regulation increases resistance to microtubule-directed chemotherapeutic agents through mammalian target of rapamycin.
VanderWeele DJ; Zhou R; Rudin CM
Mol Cancer Ther; 2004 Dec; 3(12):1605-13. PubMed ID: 15634654
[TBL] [Abstract][Full Text] [Related]
22. Quercetin suppresses the mobility of breast cancer by suppressing glycolysis through Akt-mTOR pathway mediated autophagy induction.
Jia L; Huang S; Yin X; Zan Y; Guo Y; Han L
Life Sci; 2018 Sep; 208():123-130. PubMed ID: 30025823
[TBL] [Abstract][Full Text] [Related]
23. Glycometabolic adaptation mediates the insensitivity of drug-resistant K562/ADM leukaemia cells to adriamycin via the AKT-mTOR/c-Myc signalling pathway.
Zhang X; Ai Z; Chen J; Yi J; Liu Z; Zhao H; Wei H
Mol Med Rep; 2017 Apr; 15(4):1869-1876. PubMed ID: 28259993
[TBL] [Abstract][Full Text] [Related]
24. Targeting hexokinase 2 inhibition promotes radiosensitization in HPV16 E7-induced cervical cancer and suppresses tumor growth.
Liu Y; Murray-Stewart T; Casero RA; Kagiampakis I; Jin L; Zhang J; Wang H; Che Q; Tong H; Ke J; Jiang F; Wang F; Wan X
Int J Oncol; 2017 Jun; 50(6):2011-2023. PubMed ID: 28498475
[TBL] [Abstract][Full Text] [Related]
25. Mammalian target of rapamycin promotes vincristine resistance through multiple mechanisms independent of maintained glycolytic rate.
Vanderweele DJ; Rudin CM
Mol Cancer Res; 2005 Nov; 3(11):635-44. PubMed ID: 16317089
[TBL] [Abstract][Full Text] [Related]
26. Mangiferin protects mitochondrial function by preserving mitochondrial hexokinase-II in vessel endothelial cells.
Song J; Li Y; Song J; Hou F; Liu B; Li A
Biochim Biophys Acta Mol Basis Dis; 2017 Jul; 1863(7):1829-1839. PubMed ID: 28478227
[TBL] [Abstract][Full Text] [Related]
27. Colony-stimulating factor-1 requires PI3-kinase-mediated metabolism for proliferation and survival in myeloid cells.
Lee AW; States DJ
Cell Death Differ; 2006 Nov; 13(11):1900-14. PubMed ID: 16514418
[TBL] [Abstract][Full Text] [Related]
28. Synergistic Effects between mTOR Complex 1/2 and Glycolysis Inhibitors in Non-Small-Cell Lung Carcinoma Cells.
Jiang S; Zou Z; Nie P; Wen R; Xiao Y; Tang J
PLoS One; 2015; 10(7):e0132880. PubMed ID: 26176608
[TBL] [Abstract][Full Text] [Related]
29. Inhibition of early apoptotic events by Akt/PKB is dependent on the first committed step of glycolysis and mitochondrial hexokinase.
Gottlob K; Majewski N; Kennedy S; Kandel E; Robey RB; Hay N
Genes Dev; 2001 Jun; 15(11):1406-18. PubMed ID: 11390360
[TBL] [Abstract][Full Text] [Related]
30. Naja nigricollis CMS-9 enhances the mitochondria-mediated death pathway in adaphostin-treated human leukaemia U937 cells.
Chen YJ; Wang JJ; Chang LS
Clin Exp Pharmacol Physiol; 2011 Nov; 38(11):755-63. PubMed ID: 21824174
[TBL] [Abstract][Full Text] [Related]
31. AKT mediated glycolytic shift regulates autophagy in classically activated macrophages.
Matta SK; Kumar D
Int J Biochem Cell Biol; 2015 Sep; 66():121-33. PubMed ID: 26222186
[TBL] [Abstract][Full Text] [Related]
32. TIMMDC1 Knockdown Inhibits Growth and Metastasis of Gastric Cancer Cells through Metabolic Inhibition and AKT/GSK3β/β-Catenin Signaling Pathway.
Liu Y; Huang Y; Zhang J; Pei C; Hu J; Lyu J; Shen Y
Int J Biol Sci; 2018; 14(10):1256-1267. PubMed ID: 30123074
[TBL] [Abstract][Full Text] [Related]
33. Lin28A induces energetic switching to glycolytic metabolism in human embryonic kidney cells.
Docherty CK; Salt IP; Mercer JR
Stem Cell Res Ther; 2016 May; 7(1):78. PubMed ID: 27230676
[TBL] [Abstract][Full Text] [Related]
34. Targeting the AKT/GSK3β/cyclin D1/Cdk4 survival signaling pathway for eradication of tumor radioresistance acquired by fractionated radiotherapy.
Shimura T; Kakuda S; Ochiai Y; Kuwahara Y; Takai Y; Fukumoto M
Int J Radiat Oncol Biol Phys; 2011 Jun; 80(2):540-8. PubMed ID: 21398050
[TBL] [Abstract][Full Text] [Related]
35. Leptin receptor mediates the proliferation and glucose metabolism of pancreatic cancer cells via AKT pathway activation.
Xu Y; Tan M; Tian X; Zhang J; Zhang J; Chen J; Xu W; Sheng H
Mol Med Rep; 2020 Feb; 21(2):945-952. PubMed ID: 31789415
[TBL] [Abstract][Full Text] [Related]
36. MUC1-Mediated Metabolic Alterations Regulate Response to Radiotherapy in Pancreatic Cancer.
Gunda V; Souchek J; Abrego J; Shukla SK; Goode GD; Vernucci E; Dasgupta A; Chaika NV; King RJ; Li S; Wang S; Yu F; Bessho T; Lin C; Singh PK
Clin Cancer Res; 2017 Oct; 23(19):5881-5891. PubMed ID: 28720669
[No Abstract] [Full Text] [Related]
37. SIK2 promotes reprogramming of glucose metabolism through PI3K/AKT/HIF-1α pathway and Drp1-mediated mitochondrial fission in ovarian cancer.
Gao T; Zhang X; Zhao J; Zhou F; Wang Y; Zhao Z; Xing J; Chen B; Li J; Liu S
Cancer Lett; 2020 Jan; 469():89-101. PubMed ID: 31639424
[TBL] [Abstract][Full Text] [Related]
38. Reciprocal activation between IL-6/STAT3 and NOX4/Akt signalings promotes proliferation and survival of non-small cell lung cancer cells.
Li J; Lan T; Zhang C; Zeng C; Hou J; Yang Z; Zhang M; Liu J; Liu B
Oncotarget; 2015 Jan; 6(2):1031-48. PubMed ID: 25504436
[TBL] [Abstract][Full Text] [Related]
39. INPP4B-mediated tumor resistance is associated with modulation of glucose metabolism via hexokinase 2 regulation in laryngeal cancer cells.
Min JW; Kim KI; Kim HA; Kim EK; Noh WC; Jeon HB; Cho DH; Oh JS; Park IC; Hwang SG; Kim JS
Biochem Biophys Res Commun; 2013 Oct; 440(1):137-42. PubMed ID: 24051093
[TBL] [Abstract][Full Text] [Related]
40. Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
Nagata Y; Takahashi A; Ohnishi K; Ota I; Ohnishi T; Tojo T; Taniguchi S
Int J Oncol; 2010 Oct; 37(4):1001-10. PubMed ID: 20811722
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
